Bugao, Lita L.

HRN: 02-15-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2024
CEFTRIAXONE 1G (VIAL)
03/24/2024
03/30/2024
IV
1gm
OD
Cap
Waiting Final Action 
03/29/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
03/29/2024
03/29/2024
IV
40mg
SD
HD Prophylaxis
Waiting Final Action 
03/29/2024
MUPIROCIN 2%, 15G (TUBE)
03/29/2024
03/29/2024
CUTANEOUS
Apply To Affected Areas
Now
HD Prophylaxis
Waiting Final Action 
04/02/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
04/02/2024
04/02/2024
IV
80mg
1 Dose
IJ Cath Prophylaxis
Waiting Final Action 
09/15/2024
CEFTRIAXONE 1G (VIAL)
09/15/2024
09/21/2024
IVT
2g
OD
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: